2003 AstraZeneca award in chemistry: recognizing excellence in chemistry across Canada.
Professor Hall completed his Ph.D. in 1995 at the Universite de Sherbrooke and his post-doctoral training at U.C. Berkeley. In 1997, Professor Hall joined the faculty at University of Alberta and went on to develop novel chemistry with boronic acids and boronates as a central theme. The Hall group created the ; first polystyrene resin bearing a diethanolamine group capable of immobilizing boronic acids. Additional achievements of the Hall group include the design of resin-to-resin transfer reactions of boronic acids, the discovery of the first Lewis acid-catalyzed allyl boronation, and the invention of a multicomponent reaction based on the tandem Diels-Alder/allylboronation of azaborono-butadienes.
Awarded yearly to a research group in Canada, the AstraZeneca Award in Chemistry recognizes recent outstanding contributions in chemistry. The recipient is chosen by a committee consisting of a senior academic advisor and members of the AstraZeneca R&D Montreal chemistry department. For the 2003 award, Professor Claude Spino from Universite de Sherbrooke was the senior academic advisor. The award, sponsored by AstraZeneca Canada Inc., is granted for two years with a value of $50,000 per year. This is an unrestricted grant aimed at fostering continued growth and development within the Awardee's research programs and is part of AstraZeneca's commitment to support excellence in chemistry across Canada.
For more information on the award see www.astrazeneca.ca/E/montreal/
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Dennis Hall wins the 2003 AstraZeneca Award in Chemistry|
|Publication:||Canadian Chemical News|
|Article Type:||Brief Article|
|Date:||Jul 1, 2003|
|Previous Article:||Mass spectrometry of free radicals.|
|Next Article:||"Too busy. Don't have the time ...".|